Analyze Arthritis.Com » Arthritis Treatments

NZ Green Lipped Mussel Extract; Is It A Panacea For Arthritis?

Don — Sat, 21 Nov 2009 10:37:45 +0000

Don’s Comment: Forget Glucosamine! After using NZ Green Lipped Mussel for more than twelve months with far superior results to the Glucosamine I had been using, I can’t sing the praises of this natural remedy for arthritis enough – I really do recommend you try it.

I have found the results build slowly – I only really started to notice remarkable relief after 3 months of taking the product as directed – at which point the benefits really became very noticeable. I only recommend Xtend-Life Green Lipped Mussel capsules – I’ve tried other brands but I keep coming back to the genuine quality, value and superb customer service from this small, yet highly innovative company located in the beautiful city of Christchurch, New Zealand. There’s no need to be concerned about the time frame for shipping from New Zealand – I’ve found often times my supplies arrive faster from New Zealand than my mail does from my daughter in New York. I would really appreciate comments from any of you on this post about your experiences of using Green Lipped Mussel Extract. Thanks Don.

Click here to purchase the worlds highest quality New Zealand Green Lipped Mussel Capsules at a very affordable price and free shipping.

———-

Perna canaliculus, Green-lipped mussel is a New Zealand shellfish, the extract of which has been shown to be useful in the treatment of osteoarthritis, rheumatoid Arthritis, bursitis, ankylosing spondylitis, lyme disease, skin inflammation, Connective Tissue Repair and sports related injuries.

People who use this natural supplement often rave about it’s effectiveness in treating their arthritic conditions. For further information regarding NZ Green Lipped Mussel please click here.

Law Professor Files Supreme Court Amicus Brief (Vioxx Case)

Don — Wed, 18 Nov 2009 11:04:33 +0000

[ad]

Washington and Lee University School of Law Prof. Lyman Johnson filed in October an amicus brief with the U.S. Supreme Court in the case Merck & Co. v. Reynolds.

The case involves a class-action lawsuit by Merck’s shareholders alleging the pharmaceutical company provided misleading information about the risks of Vioxx before pulling the pain reliever from the market due to increased risks of heart attack, stroke and death. The company moved to dismiss the claim, arguing that investors had been put on “inquiry notice” more than two years before they filed suit and that the statute of limitations of the claim had expired. Read the full Vioxx article here.

Source: rockbridgeweekly.com

No related posts.

People With Low Levels Of ‘Celebrex Gene’ Are Resistant To Preventative Celebrex Treatment

Don — Mon, 16 Nov 2009 23:43:01 +0000

[ad]

A new study finds that individuals who have low expression of the “Celebrex gene,” 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon cancer. The study, published in this week’s issue of the Proceedings of the National Academy of Sciences (PNAS), is by Sanford Markowitz, M.D., Ph.D. – read the full Celebrex study article here.

No related posts.

Pfizer Subsidiary Hit With Record $1.2 Billion Fine For Bextra Fraud.

Don — Sun, 15 Nov 2009 21:48:35 +0000

[ad]

Pfizer Inc. subsidiary Pharmacia & Upjohn Co. has been sentenced to pay the largest criminal fine ever imposed in the U.S. for misbranding the arthritis pain medication Bextra, the U.S. Justice Department said late Friday. The Pfizer unit must pay a criminal fine of just under $1.2 billion and a criminal forfeiture of $105 million, the U.S. Justice Department said in a statement. Read the full Bextra fraud article here.

Source: MarketWatch.Com

No related posts.

Study Finds Glucosamine Not Beneficial For Osteoarthritis

Don — Wed, 11 Nov 2009 10:13:04 +0000

[ad]

Those suffering from cartilage loss due to the effects of osteoarthritis will be disappointed to hear the results of research conducted by the University of Pittsburgh.

Dr. C. Kent Kwoh, professor of medicine and epidemiology in the university’s division of rheumatology and clinical immunology studied 201 people over 24 weeks. One positive aspect of the results is that Glucosamine may have a role to play in managing the related pain of osteoarthritis but not in repairing the joint itself.

The results of the study on glucosamine and osteoarthritis make informative reading. Read the full glucosamine/osteoarthritis article here.

Source: Healthscout.com

Study Concludes Magnetic and Copper Bracelets Don’t Relieve Arthritis Pain [ad] Given the world-wide interest in magnets and copper bracelets as a means of relieving or eliminating arthritis pain, a placebo-controlled study by a research...
Hedgehog Proteins May Hold Key To Osteoarthritis Pain Relief [ad] Canadian scientists believe they may have found a promising target for developing new osteoarthritis treatments. Researchers at the University of Toronto and the Hospital...
New Study Finds 56% Higher Odds of Osteoarthritis in Abused Kids. [ad] A new study by the University of Toronto has determined a substantial link between physical abuse in childhood and osteoarthritis in adulthood. Adults who...

Arthritis Drugs May be Causing Cancer in Children

Don — Sun, 01 Nov 2009 01:40:26 +0000

[ad]

The FDA reports today that a family of drugs known as TNF blockers (designed to interfere with a chemical in the body which causes inflammation) and which are used in the treatment of rheumatoid arthritis and juvenile arthritis, might be causing cancer in children and young adults. The brands under investigation include; Remicade, Humira, and Enbrel. More than 30 cases of cancer in the young who were taking these drugs have been reported over the last 10 years … read more here.

Source: NaturalNews.com

Ankylosing Spondylitis (Arthritis of the Spine) Targets Young Men. [ad] Ankylosing Spondylitis (AS), more commonly known as “arthritis of the spine” is not easily diagnosed. The disease has a predisposition to attacking young males...